Clopidogrel vs aspirin monotherapy beyond 1 year after percutaneous coronary intervention
H Watanabe, T Morimoto, M Natsuaki… - Journal of the American …, 2024 - jacc.org
Background It remains unclear whether clopidogrel is better suited than aspirin as the long-
term antiplatelet monotherapy following dual antiplatelet therapy (DAPT) after percutaneous …
term antiplatelet monotherapy following dual antiplatelet therapy (DAPT) after percutaneous …
Clopidogrel vs aspirin monotherapy following dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and meta-analysis
Current guidelines recommend 6-12 months of dual antiplatelet therapy (DAPT) after
percutaneous coronary intervention (PCI) followed by aspirin monotherapy indefinitely. We …
percutaneous coronary intervention (PCI) followed by aspirin monotherapy indefinitely. We …
Aspirin versus clopidogrel for long-term maintenance monotherapy after percutaneous coronary intervention: the HOST-EXAM extended study
J Kang, KW Park, H Lee, D Hwang, HM Yang… - Circulation, 2023 - Am Heart Assoc
Background: Long-term outcomes of antiplatelet monotherapy in patients who receive
percutaneous coronary intervention are unknown. The HOST-EXAM (Harmonizing Optimal …
percutaneous coronary intervention are unknown. The HOST-EXAM (Harmonizing Optimal …
Clopidogrel versus aspirin as an antiplatelet monotherapy after 12-month dual-antiplatelet therapy in the era of drug-eluting stents
TK Park, YB Song, J Ahn, KC Carriere… - Circulation …, 2016 - Am Heart Assoc
Background—The use of dual-antiplatelet therapy (DAPT) exceeding 12 months may
increase a bleeding risk despite a lower risk of ischemic events. There is no study to …
increase a bleeding risk despite a lower risk of ischemic events. There is no study to …
Long-term clopidogrel monotherapy after percutaneous coronary intervention: will the pupil surpass the master?
L Ortega-Paz, M Sabaté, DJ Angiolillo - Journal of the American College of …, 2023 - jacc.org
Long-term use of low-dose aspirin monotherapy is a Class I guideline-recommended
treatment in patients with prior myocardial infarction (MI), stroke, or coronary …
treatment in patients with prior myocardial infarction (MI), stroke, or coronary …
Clopidogrel monotherapy after 1-month dual antiplatelet therapy in percutaneous coronary intervention: from the STOPDAPT-2 total cohort
Y Obayashi, H Watanabe, T Morimoto… - Circulation …, 2022 - Am Heart Assoc
Background: The benefit of clopidogrel monotherapy after 1-month dual antiplatelet therapy
(DAPT) compared with 12-month DAPT with aspirin and clopidogrel was demonstrated in …
(DAPT) compared with 12-month DAPT with aspirin and clopidogrel was demonstrated in …
Comparison of the impact of short (< 1 year) and long-term (≥ 1 year) clopidogrel use following percutaneous coronary intervention on mortality
S Banerjee, C Varghese, J Samuel… - The American journal of …, 2008 - Elsevier
The optimal duration of clopidogrel administration after percutaneous coronary intervention
(PCI) remains unknown. Clopidogrel is currently recommended for minimums of 1 and 12 …
(PCI) remains unknown. Clopidogrel is currently recommended for minimums of 1 and 12 …
Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving …
H Watanabe, T Domei, T Morimoto, M Natsuaki… - Jama, 2019 - jamanetwork.com
Importance Very short mandatory dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention (PCI) with a drug-eluting stent may be an attractive option. Objective …
coronary intervention (PCI) with a drug-eluting stent may be an attractive option. Objective …
Clopidogrel monotherapy vs. aspirin monotherapy following short-term dual antiplatelet therapy in patients receiving everolimus-eluting coronary stent implantation
M Natsuaki, T Morimoto, H Watanabe, M Abe… - Circulation …, 2020 - jstage.jst.go.jp
Background: There is a scarcity of data on short-duration dual antiplatelet therapy (DAPT)
followed by P2Y12 inhibitor monotherapy as compared with aspirin monotherapy after …
followed by P2Y12 inhibitor monotherapy as compared with aspirin monotherapy after …
Impact of high loading and maintenance dose of clopidogrel within the first 15 days after percutaneous coronary intervention on patient outcome
G Lemesle, C Delhaye, A Sudre, D Broucqsault… - American heart …, 2009 - Elsevier
BACKGROUND: An increase in clopidogrel dose results in an improved inhibition of platelet
aggregation. However, whether an increase in clopidogrel dose may improve patient …
aggregation. However, whether an increase in clopidogrel dose may improve patient …